PROM1 and central nervous system cancer: The CD133 positive tumor cells are proposed to be involved in radio- and chemoresistance [3] and the detected co-expression with Oct-4 may suggest that Oct-4 also play a role in maintaining this therapeutically resistant type of glioma cells.